Literature DB >> 23165463

Case report of exposure to voriconazole in the second and third trimesters of pregnancy.

M Shoai Tehrani, F Sicre de Fontbrune, P Roth, C Allisy, M-E Bougnoux, O Hermine, M Lecuit, O Lortholary, C Charlier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23165463      PMCID： PMC3553730          DOI： 10.1128/AAC.00899-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  8 in total

1.  Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for fast and accurate identification of clinically relevant Aspergillus species.

Authors:  A Alanio; J-L Beretti; B Dauphin; E Mellado; G Quesne; C Lacroix; A Amara; P Berche; X Nassif; M-E Bougnoux
Journal:  Clin Microbiol Infect       Date:  2011-05       Impact factor: 8.067

2.  Prenatal exposure to fluconazole: an identifiable dysmorphic phenotype.

Authors:  Elena Lopez-Rangel; Margot Isham Van Allen
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2005-11

3.  Safety of fluconazole in the treatment of vaginal candidiasis. A prescription-event monitoring study, with special reference to the outcome of pregnancy.

Authors:  W Inman; G Pearce; L Wilton
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

4.  Fluconazole-induced congenital anomalies in three infants.

Authors:  T J Pursley; I K Blomquist; J Abraham; H F Andersen; J A Bartley
Journal:  Clin Infect Dis       Date:  1996-02       Impact factor: 9.079

Review 5.  Azole-resistance in Aspergillus: proposed nomenclature and breakpoints.

Authors:  Paul E Verweij; Susan J Howard; Willem J G Melchers; David W Denning
Journal:  Drug Resist Updat       Date:  2009-10-29       Impact factor: 18.500

Review 6.  Antifungal drugs in pregnancy: a review.

Authors:  Varsha V Moudgal; Jack D Sobel
Journal:  Expert Opin Drug Saf       Date:  2003-09       Impact factor: 4.250

7.  Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.

Authors:  Andres Pascual; Thierry Calandra; Saskia Bolay; Thierry Buclin; Jacques Bille; Oscar Marchetti
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

8.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079
  8 in total
  1 in total

1.  Invasive sino-orbital aspergillosis with brain invasion in an immunocompetent pregnant patient.

Authors:  Hamad M Alsulaiman; Sahar M Elkhamary; Mohammed Alrajeh; Osama Al-Alsheikh; Huda Al-Ghadeer
Journal:  Am J Ophthalmol Case Rep       Date:  2021-09-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.